Use access key #2 to skip to page content.

A Conversation with ZZlangerhans

Recs

25

February 17, 2011 – Comments (10)

When he's not working with FloridaBuilder to inspire stock pick haikus, ZZ is our resident biotech expert. 

Click here to read  part one of my two part interview. From the interview:

Another of my recent trades is Alimera Sciences (Nasdaq: ALIM), who in December received a surprising Complete Response Letter from the FDA for the Iluvien ocular implant for diabetic macular edema. I saw the CRL as a "soft" rejection with no additional clinical trials required, but the effect of the rejection on the share price was proportionately mild. I took a position in CAPS to help me monitor the stock and waited, and eventually the share price degraded to the point where I felt a trade was warranted. I bought 2000 shares at 9 which almost immediately rose to 10.3. In 2010 I would likely have booked my profit, but since I left so much money on the table last year I decided to keep holding through the Iluvien resubmission. Subsequent extended data from the Iluvien clinical trial dropped the share price back down to 8.5, so the conclusion of this story is yet to be seen.

10 Comments – Post Your Own

#1) On February 17, 2011 at 2:54 PM, binve (< 20) wrote:

Excellent interview! Thanks Jake and ZZ!

Report this comment
#2) On February 17, 2011 at 2:56 PM, Option1307 (29.92) wrote:

Pure awesomeness, thanks Jake!

Report this comment
#3) On February 17, 2011 at 3:02 PM, Momentum21 (84.91) wrote:

well-deserved recognition for ZZ

Report this comment
#4) On February 17, 2011 at 3:13 PM, whereaminow (45.39) wrote:

Great stuff! 

David in Qatar

Report this comment
#5) On February 17, 2011 at 4:03 PM, lemoneater (75.49) wrote:

As great as the above achievement was, I will remember ZZlangerhans most for redefining "renaissance man" as someone who can give viable stock pitches in haiku form.

Report this comment
#6) On February 17, 2011 at 4:17 PM, cecamadocv1 (99.97) wrote:

Nice article...

 

I have to say even thou zzlangerhans targeted me in one of my pitches because of a honest mistake.  

 he is defintiely one of my favorite people to follow on Caps.

If I ever ran a Fund, langerzans, TMFsinchura guy, vanamonde would definitely be a part of it ..  GoodJob guys

 

Report this comment
#7) On February 17, 2011 at 6:16 PM, portefeuille (99.60) wrote:

Paul Langerhans.

Report this comment
#8) On February 18, 2011 at 12:55 AM, Momentum21 (84.91) wrote:

He is a hybrid between Mr Dax and Langerhans... 

 

Report this comment
#9) On February 18, 2011 at 9:05 AM, Pick1es (20.48) wrote:

It's interesting to note the difference in personality between CAPS players that post on the front page articles, and the players who are active in the blogs.

Report this comment
#10) On February 18, 2011 at 4:01 PM, portefeuille (99.60) wrote:

An Inside Look at Biotech Investing, Part 2

Report this comment

Featured Broker Partners


Advertisement